Inflammation-modulating cytokine profile and lipid interaction in HIV-related risk factors for cardiovascular diseases

References

• TrøseidMMannerIWPedersenKKHaissmanJMKvaleDNielsenSDMicrobial translocation and cardiometabolic risk factors in HIV infectionAIDS Res Hum Retroviruses201430651452224521167
   PubMed Web of Science ®Google Scholar
• CuiHLDitiatkovskiMKesaniRHIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosisFASEB J20142872828283924642731
   PubMed Web of Science ®Google Scholar
• CroweSMWesthorpeCLVMukhamedovaNJaworowskiASviridovDBukrinskyMThe macrophage: the intersection between HIV infection and atherosclerosisJ Leukoc Biol201087458959819952353
   PubMed Web of Science ®Google Scholar
• EstradaVPortillaJDyslipidemia related to antiretroviral therapyAIDS Rev2011131495621412389
   PubMed Web of Science ®Google Scholar
• FeeneyERMallonPWHIV and HAART-associated dyslipidemiaOpen Cardiovasc Med J20115496321643501
   PubMedGoogle Scholar
• TrollJGApproach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infectionCurr Atheroscler Rep2011131515621181310
   PubMed Web of Science ®Google Scholar
• Friis-MøllerNWeberRReissPCardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD studyAIDS20031781179119312819520
   PubMed Web of Science ®Google Scholar
• AdewoleOOEzeSYeBLipid profile in HIV/AIDS patients in NigeriaAfr Health Sci201010214414921326966
   PubMed Web of Science ®Google Scholar
• SouzaSJLuziaLASantosSSRondóPHLipid profile of HIV-infected patients in relation to antiretroviral therapy: a reviewRev Assoc Med Bras201359218619823582562
   PubMed Web of Science ®Google Scholar
• PodzamczerDLipid metabolism and cardiovascular risk in HIV infection: new perspectives and the role of nevirapineAIDS Rev201315419520324192600
   PubMed Web of Science ®Google Scholar
• XiaoQKiechlSPatelSEndothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis–results from a large population-based studyPLoS One2007210e97517925881
   PubMed Web of Science ®Google Scholar
• AndradeACCotterBREndothelial function and cardiovascular diseases in HIV infected patientBraz J Infect Dis200610213914516878266
   PubMedGoogle Scholar
• LedruEChristeffNPateyOde TruchisPMelchiorJCGougeonMLAlteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndromeBlood200095103191319810807787
   PubMed Web of Science ®Google Scholar
• CroweSMHoyJFAre monocytes the canary in the coal mine for HIV-related atherosclerosis?J Infect Dis2012206101491149323066161
   PubMed Web of Science ®Google Scholar
• GibelliniDBorderiMCloAHIV-related mechanisms in atherosclerosis and cardiovascular diseasesJ Cardiovasc Med20131411780790
   Google Scholar
• NunezEAChristeffNSteroid hormone, cytokine, lipid and metabolic disturbances in HIV infectionBaillieres Clin Endocrinol Metab1994848038247811223
   PubMed Web of Science ®Google Scholar
• FeingoldKRSouedMSerioMKMoserAHDinarelloCAGrunfeldCMultiple cytokines stimulate hepatic lipid synthesis in vivoEndocrinology198912512672742661207
   PubMed Web of Science ®Google Scholar
• JohnsonJAAlbuJBEngelsonESIncreased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophyAm J Physiol Endocrinol Metab20042862E261E27114532165
   PubMed Web of Science ®Google Scholar
• BarbaroGIacobellisGMetabolic syndrome associated with HIV and highly active antiretroviral therapyCurr Diab Rep200991374219192423
   PubMed Web of Science ®Google Scholar
• FeingoldKRGrunfeldCRole of cytokines in inducing hyperlipidemiaDiabetes199241971011526345
   PubMed Web of Science ®Google Scholar
• McLarenJEMichaelDRAshlinTGRamjiDPCytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapyProg Lipid Res201150433134721601592
   PubMed Web of Science ®Google Scholar
• AbergJACardiovascular complications in HIV management: past, present, and futureJ Acquir Immune Defic Syndr2009501546419295335
   PubMed Web of Science ®Google Scholar
• TsaoCHShiauMYChuangPHChangYHHwangJInterleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysisJ Lipid Res201455338539724347527
   PubMed Web of Science ®Google Scholar
• HanXKitamotoSWangHBoisvertWAInterleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic miceFASEB J20102482869288020354139
   PubMed Web of Science ®Google Scholar
• HanXKitamotoSLianQBoisvertWAInterleukin-10 facilitates both cholesterol uptake and efflux in macrophagesJ Biol Chem200928447329503295819776020
   PubMed Web of Science ®Google Scholar
• NguemaïmNFMbuagbawJNkoaTSerum lipid profile in highly active antiretroviral therapy-naïve HIV-infected patients in Cameroon: a case-control studyHIV Med201011635335920345886
   PubMed Web of Science ®Google Scholar
• PiddubnaAIChemychMDIL-4, IL-10, TNF-α profile and immunological changes in North-Eastern Ukrainian HIV-infected individualsHIV AIDS Rev2013126872
   Google Scholar
• OrsillesMAPieriECookePCaulaCIL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapyAPMIS20061141556016499662
   PubMed Web of Science ®Google Scholar
• MoraitisAGFreemanLAShamburekRDElevated interleukin-10: a new cause of dyslipidemia leading to severe HDL-c deficiencyJ Clin Lipidol201591819025670364
   PubMed Web of Science ®Google Scholar
• PadmapriyadarsiniCRamesh KumarSTerrinNDyslipidemia among HIV-infected patients with tuberculosis taking once-daily non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in IndiaClin Infect Dis201152454054621252141
   PubMed Web of Science ®Google Scholar
• DenueBAAlkaliMBAbjahAUKidaIMAjayiBFateBZChanges in lipid profiles and other biochemical parameters in HIV-1 infected patients newly commenced on HAART regimenInfect Dis20136714
   PubMedGoogle Scholar
• MalapatiBPatelBShahRMChanges in lipid profiles and other biochemical parameters in HIV-1 infected patientsInt J Med Sci Public Health201437813817
   Google Scholar
• TanjekoATKwentiTENkumeFAChongsiMEMbuntumJFBainLEChanges in lipid profile and body mass index in HIV/AIDS patients on antiretroviral and anti-tuberculosis therapies in CameroonRes J Pharm Biol Chem Sci20145612751283
   Google Scholar
• MankhatithamWLuaengniyomkulAManosuthiWLipid profile changes in Thai HIV and tuberculosis co-infected patients receiving non-nucleoside reverse transcriptase inhibitors-based antiretroviral therapyJ Med Assoc Thai201295216316922435244
   PubMedGoogle Scholar
• ImamiNAntonopoulosCHardyGADGazzardBGotchFMAssessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapyAIDS Res Hum Retroviruses199915171499150810580400
   PubMed Web of Science ®Google Scholar
• VecchietJDalessandroMTravasiFInterleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapyInt J Immunopathol Pharmacol200316215716612797907
   PubMed Web of Science ®Google Scholar
• MendallMAPatelPAsanteMRelation of serum cytokine concentrations to cardiovascular risk factors and coronary heart diseaseHeart19977832732779391290
   PubMed Web of Science ®Google Scholar
• CerviaJSChantryCJHughesMDIiiWAMHodgeJBorumPAssociations of proinflammatory cytokine levels with lipid profiles, growth, and body composition in HIV-infected children initiating or changing antiretroviral therapyPediatr Infect Dis J201029121118112220631646
   PubMed Web of Science ®Google Scholar
• MaherBLloydJWilkinsEGLLipodystrophy in patients with HIV-1 infection: effect of stopping protease inhibitors on TNF-α and TNF-receptor levels, and on metabolic parametersAntivir Ther20049687988715651746
   PubMed Web of Science ®Google Scholar
• NemauraTDhoroMNhachiCKadzirangeGChonziPMasimirembwaCValuation of the prevalence, progression and severity of common adverse reactions (lipodystrophy, CNS, peripheral neuropathy, and hypersensitivity reactions) associated with anti-retroviral therapy (ART) and anti-tuberculosis treatment in outpatients in ZimbabweJ AIDS Clin Res20134203
   Google Scholar
• SavesMCheneGDucimetierePRisk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general populationClin Infect Dis200337229229812856222
   PubMed Web of Science ®Google Scholar
• Pontes-CardosoLCRSouzaLRPeraçoliMTSPereiraPCMCytokines profile and clinical-metabolic alterations in HIV-1-infected individuals with and without lypodistrophyJ Venom Anim Toxins Trop Dis2007132509526
   Web of Science ®Google Scholar
• OkaFNaitoTOikeMCorrelation between HIV disease and lipid metabolism in antiretroviral-naıve HIV-infected patients in JapanJ Infect Chemother2012181172121735099
   PubMed Web of Science ®Google Scholar
• CalmyAGayet-AgeronAMontecuccoFHIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trialAIDS200923892993919425222
   PubMed Web of Science ®Google Scholar